SRI International to Host 14th Annual Biotech Investing Conference
MENLO PARK, Calif. -- October 23, 2006 -- SRI International, an independent nonprofit research and development organization, today announced it is hosting IBF International Business Forum’s 14th Annual Biotech Investing Conference on November 8, 2006 at SRI headquarters in Menlo Park, Calif. The conference, titled "Rebuilding the Pipeline," is a platform for industry leaders in biotech to discuss early, mid and late investing.
The conference is an industry gathering for venture capitalists, private equity investors, biotech companies, big pharmaceuticals, endowments and foundation executives, corporate strategic investors, institutional investors, licensing executives, and commercial and investment bankers.
At the conference, presenters will discuss the latest initiatives in biotech investing and focus on themes such as:
- Trends in early, mid and late-stage biotech investing
- Hedge fund/private equity appetite for biotech
- How foundations "bridge the gap": Partnering with VCs and entrepreneurs to fund early-stage biotech companies
- Large pharmaceutical company approaches to filling the pipeline
- FDA-accelerated drug development programs
For more information, or to register for the 14th Annual Biotech Investing Conference, please visit the IBF Conference web site at: www.ibfconferences.com.
About SRI International
Silicon Valley-based SRI International (http://www.sri.com) is one of the world’s leading independent research and technology development organizations. Founded as Stanford Research Institute in 1946, SRI has been meeting the strategic needs of clients for 60 years. The nonprofit research institute performs client-sponsored research and development for government agencies, commercial businesses, and private foundations. In addition to conducting contract R&D, SRI licenses its technologies, forms strategic partnerships, and creates spin-off companies.
# # #
